Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study

Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Katende, Bulemba, Fernández, Lucia González, Muhairwe, Josephine, Glass, Tracy R., Ayakaka, Irene, Labhardt, Niklaus D., Ruhwald, Morten, de Vos, Margaretha, Bresser, Moniek, Reither, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630292/
https://www.ncbi.nlm.nih.gov/pubmed/36345367
http://dx.doi.org/10.1016/j.ijregi.2022.10.007
Descripción
Sumario:Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.

Ejemplares similares